Balyasny Asset Management LLC Oric Pharmaceuticals, Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,555,260 shares of ORIC stock, worth $13 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,555,260
Previous 1,131,066
37.5%
Holding current value
$13 Million
Previous $11.6 Million
8.25%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ORIC
# of Institutions
131Shares Held
67.3MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$44.2 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$40.4 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$37 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$36.7 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$32.6 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $331M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...